Immunogenicity of an aphthovirus chimera of the glycoprotein of vesicular stomatitis virus

Journal of Virology

Volumn 70, Issue 12, 1996, Pages 8492-8501

  Grigera, Pablo R ^a,b   Garcia Briones, Mercedes ^a   Periolo, Osvaldo ^a   La Torre, Jose L ^a   Wagner, Robert R ^b,c  

^a Centro de Virologia Animal   (Argentina)

^b UNIVERSITY OF VIRGINIA   (United States)

^c UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS GLYCOPROTEIN;

ANIMAL CELL; ANTIBODY TITER; ANTIGEN BINDING; ARTICLE; BACTERIOPHAGE; BINDING KINETICS; CHIMERA; CONCENTRATION RESPONSE; FOOT AND MOUTH DISEASE VIRUS; IMMUNOGENICITY; INSECT; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; VESICULAR STOMATITIS VIRUS;

EID: 0029956766     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.12.8492-8501.1996     Document Type: Article

References (40)

1. Acharya, R., E. Fry, D. Stuart, G. Fox, D. Rowlands, and F. Brown. 1989. The three dimensional structure of foot-and-mouth disease virus at 2.9A resolution. Nature (London) 337:709-716.
2. Baxt, B., and Y. Becker. 1990. The effect of peptides containing the arginine-glycine-aspartic acid sequence on the adsorption of foot-and-mouth disease virus to tissue culture cells. Virus Genes 4:73-83.
3. Beesley, K. M., M. J. Francis, B. E. Clarke, J. E. Beesley, P. J. C. Dopping-Hepenstal, J. J. Clare, F. Brown, and M. A. Romanos. 1990. Expression in yeast of amino terminal fusions to hepatitis B core antigen and their immunulogical properties. Bio/Technology 8:644-649.
4. Bolwell, C., N. R. Parry, and D. J. Rowlands. 1992. Comparison between in vitro neutralization titres and in vivo protection against homologous and heterologous challenge induced by vaccines prepared from two serologically distinct variants of foot-and-mouth disease virus, serotype A22. J. Gen. Virol. 73:727.
5. Bricker, B., R. M. Snyder, J. W. Fox, W. A. Volk, and R. R. Wagner. 1987. Monoclonal antibodies to the glycoprotein of vesicular stomatitis virus (New Jersey serotype): a method for preliminary mapping of the epitopes. Virology 161:533-540.
6. Burkhart, C., G. Freer, R. Castro, L. Adorini, K. H. Wiesmuller, R. M. Zinkernagel, and H. Hengartner. 1994. Characterization of T-helper epitopes of the glycoprotein of vesicular stomatitis virus. J. Virol. 68:1573-1580.
7. Denoya, C. D., E. A. Scodeller, B. H. Gimenez, C. Vasquez, and J. L. La Torre. 1979. Foot and mouth disease virus. I. Stability of its ribonucleic acid. Virology 84:230-235.
8. Di Marchi, R., G. Brocchi, C. Gale, V. Cracknell, T. Doel, and N. Mowat. 1986. Protection of cattle against foot-and mouth-disease virus by a synthetic peptide. Science 232:639-641.
9. Feigelstock, D., M. G. Mateu, M. E. Piccone, F. De Simone, E. Brocchi, E. Domingo, and E. L. Palma. 1992. Extensive antigenic diversification of FMDV by amino acid substitutions outside the major antigenic site. J. Gen. Virol. 73:3307-3311.
10. 9a.Fitzmaurice, C. J., L. E. Brown, T. L. McInerney, and D. C. Jackson. 1996. The assembly and immunological properties of non-linear synthetic immunogens containing T-cell and B-cell determinants. Vaccine 14:553-560.
11. Fox, G., N. R. Parry, P. V. Barnett, B. McGinn, D. J. Rowlands, and F. Brown. 1989. The cell attachment site on foot-and-mouth disease virus includes the amino acid sequence RGD (arginine-glycine-aspartic acid). J. Gen. Virol. 70:625-637.
12. Francis, M. J., G. Z. Hastings, B. E. Clarke, A. L. Brown, C. R. Beddell, D. J. Rowlands, and F. Brown. 1990. Neutralizing antibodies to all seven serotypes of foot-and-mouth disease virus elicited by synthetic peptides. Immunology 69:171-176.
13. Freer, G., C. Burkhart, I. Ciernik, M. F. Bachman, H. Hengartner, and R. M. Zinkernagel. 1994. Vesicular stomatitis virus Indiana glycoprotein as a T cell dependent and independent antigen. J. Virol. 68:3650-3655.
14. Grigera, P. R., W. Keil, and R. R. Wagner. 1992. Disulfide bonded discontinuous epitopes on the glycoprotein of vesicular stomatitis virus (New Jersey serotype). J. Virol. 66:3749-3757.
15. Grigera, P. R., M. E. Mathieu, and R. R. Wagner. 1991. Effect of glycosylation on the conformational epitopes of the glycoprotein of vesicular stomatitis virus (New Jersey serotype). Virology 180:1-9.
16. Harrison, S. C. 1989. Picornavirus. Finding the receptors. Nature (London) 338:205-207.
17. Keil, W., and R. R. Wagner. 1989. Epitope mapping by deletion mutants and chimeras of two vesicular stomatitis virus glycoprotein genes expressed by vaccinia virus vectors. Virology 170:392-407.
18. Kelley, J. M., S. U. Emerson, and R. R. Wagner. 1972. The glycoprotein of vesicular stomatitis virus is the antigen that gives rise to and reacts with neutralizing antibody. J. Virol. 10:1231-1235.
19. Kitson, J. D., K. L. Burke, L. A. Pullen, G. J. Belsham, and J. W. Almond. 1991. Chimeric poliovirus that includes sequences derived from two independent antigenic sites of foot-and-mouth disease virus (FMDV) induce neutralizing antibodies against FMDV in guinea pigs. J. Virol. 65:3068-3075.
20. Kundig, T. M., I. Castelmur, M. F. Bachman, D. Abraham, D. Binder, H. Hengartner, and R. M. Zinkernagel. 1993. Fewer protective cytotoxic T cell epitopes that T helper epitopes on vesicular stomatitis virus. J. Virol. 67: 3680-3683.
21. Lea, S., J. Hernandez, W. Blakemore, E. Brocchi, S. Curry, E. Domingo, E. Fry, R. Abu-Ghazaleh, A. King, and J. Newman. 1994. The structure and antigenicity of a type C foot-and-mouth disease virus. Structure 2:123-139.
22. Lewis, S. A., D. O. Morgan, and M. J. Grubman. 1991. Expression, processing and assembly of foot-and-mouth disease virus capsid structures in heterologous systems: induction of a neutralizing antibody response in guinea pigs. J. Virol. 65:6572-6580.
23. Logan, D., R. Abu-Ghazaleh, W. Blakemore, S. Curry, T. Jaekson, A. King, S. Lea, R. Lewis, J. Newman, and N. Parry. 1993. Structure of the major immunogenic site on foot-and-mouth disease virus. Nature (London) 362: 566-588.
24. Machamer, C. E., R. W. Doms, D. G. Bole, A. Helenius, and J. K. Rose. 1990. Heavy chain binding protein recognizes incompletely disulfide bonded forms of the vesicular stomatitis virus G protein. J. Biol. Chem. 265:6879-6883.
25. Mackett, M., T. Yilma, J. K. Rose, and B. Moss. 1985. Vaccinia virus recombinant: expression of VSV genes and protective immunization of mice and cattle. Science 227:433-435.
26. Martinez, M. A., J. Hernandez, M. E. Picconi, E. L. Palma, E. Domingo, N. Knowles, and M. E. Mateu. 1991. Two mechanisms of antigenic diversification of foot-and-mouth disease virus. Virology 184:695-706.
27. Mason, P. W., E. Rieder, and B. Baxt. 1994. RGD sequence of foot-and-mouth disease virus is essential for infecting cells via the natural receptor but can be bypassed by an antibody-dependent enhancement pathway. Proc. Natl. Acad. Sci. USA 91:1932-1936.
28. Mateu, M. G., J. A. Camarero, E. Giralt, D. Andreu, and E. Domingo. 1995. Direct evaluation of the immunodominance of a major antigenic site of foot-and-mouth disease virus in a natural host. Virology 206:298-306.
29. Mateu, M. G., M. A. Martinez, L. Capucci, D. Andreu, E. Giralt, F. Sobrino, E. Brocchi, and E. Domingo. 1990. A single amino acid substitution affects multiple overlapping epitopes in the major antigenic site of foot-and-mouth disease virus of serotype C. J. Gen. Virol. 71:629-663.
30. Mathieu, M. R., P. R. Grigera, A. Helenius, and R. R. Wagner. 1996 Folding, unfolding and refolding of the vesicular stomatitis virus glycoprotein. Biochemistry 35:4084-4093.
31. McCullough, K. C., F. De Simone, E. Brocchi, L. Capucci, J. R. Crowther, and U. Kihm. 1992. Protective immune response against foot-and-mouth disease virus. J. Virol. 66:1835-1840.
32. Meloen, R. H., J. I. Casal, D. Dalsgaard, and J. P. M. Langeveld. 1995. Synthetic peptide vaccines: success at last. Vaccine 13:885-886.
33. Moss, B., O. Elroy-Stein, T. Mizukami, W. A. Alexander, and T. R. Fuerst. 1990. Product review: new mammalian expression vectors. Nature (London) 348:91-92.
34. Mulcahy, G., C. Gale, P. Robertson, S. Iyisan, R. D. DiMarchi, and T. R. Doel. 1990. Isotype responses of infected, virus-vaccinated and peptide-vaccinated cattle to foot-and-mouth disease virus. Vaccine 8:249-255.
35. Murphy, B. R., and R. M. Chanock. 1996. Immunization against virus disease, p. 467-497. In B. N. Fields, D. M. Knipe, and P. M. Howley (ed.), Field's virology, 3rd ed. Lippincott-Raven, Philadelphia.
36. O'Reilly, D., L. K. Miller, and V. A. Luckow. 1992. Baculovirus expression vectors: a laboratory manual. W. H. Freeman & Company, New York.
37. Periolo, O. H., C. Seki, P. R. Grigera, B. Robiolo, G. Fernandez, E. Maradei, and J. L. La Torre. 1993. Large-scale use of liquid-phase blocking sandwich ELISA for the evaluation of protective immunity against aphthovirus in cattle vaccinated with oil-adjuvanted vaccines in Argentina. Vaccine 11:754-760.
38. Rieder, E., B. Baxt, J. Lubroth, and P. W. Mason. 1994. Vaccines prepared from chimeras of foot-and-mouth disease virus (FMDV) induce neutralizing antibodies and protective immunity to multiple serotypes of FMDV. J. Virol. 68:7092-7098.
39. Steward, M. W., C. M. Stanley, R. Di Marchi, G. Mulcahy, and T. R. Doel. 1991. High-affinity antibody induced by immunization with synthetic peptide is associated with protection of cattle against foot-and-mouth disease. Immunology 72:99-103.
40. Strohmahier, K., R. Frame, and K. H. Adam. 1982. Location and characterization of the antigenic portion of the FMDV immunizing protein. J. Gen. Virol. 59:295-306.